{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000145","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.926357+00:00","generated_at":"2026-05-17T03:54:11.886988+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"confidence":"high","headline":"Salarius regains Nasdaq equity compliance; fully compliant ahead of Decoy merger","bullets":["Received Nasdaq letter on Oct 10, 2025 confirming compliance with minimum stockholders' equity requirement (Rule 5550(b)(1)).","Now fully compliant with all Nasdaq listing requirements, having also regained bid price compliance on Sept 9, 2025.","Subject to a Mandatory Panel Monitor for one year from Oct 10, 2025; noncompliance could lead to delisting without a cure period.","Planned merger with Decoy Therapeutics (announced Jan 13, 2025) remains on track; combined company to be named Decoy Therapeutics.","Post-merger pipeline includes pan-coronavirus antiviral IND filing within 12 months and data from MD Anderson seclidemstat study."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000145","json":"https://secwatch.observer/filing/0001615219-25-000145.json","markdown":"https://secwatch.observer/filing/0001615219-25-000145.md","text":"https://secwatch.observer/filing/0001615219-25-000145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000145/0001615219-25-000145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000145/flks-20251010.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:54:11.886988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}